Edgewise Therapeutics, Inc. Share Price
NASDAQ: EWTX | Mid CapEdgewise Therapeutics, Inc. Stock Performance
Open $43.99 | Prev. Close $44.29 | Circuit Range N/A |
Day Range $42.73 - $44.02 | Year Range $13.69 - $48.36 | Volume 36,601 |
Average Traded $43.21 |
Edgewise Therapeutics, Inc. Share Price Today
As of 30 August 2026, Edgewise Therapeutics, Inc.'s share price is $42.77. The stock opened at $43.99, compared to its previous close of $44.29. During today's trading session, Edgewise Therapeutics, Inc.'s share price traded between $42.73 and $44.02, with an average price of $43.38. Over the past 52 weeks, the stock has recorded a high of $48.36 and a low of $13.69. In terms of performance, Edgewise Therapeutics, Inc.'s share price has risen by 40.55% over the last six months and is up 197.88% on a year-on-year basis.
Edgewise Therapeutics, Inc. Share Price Chart
Edgewise Therapeutics, Inc. Stock Fundamentals & Key Indicators
Market Cap $4.40B | PE Ratio (TTM) -26.24 | Dividend Yield N/A |
EPS (TTM) $-1.63 | Revenue (TTM) N/A | Return On Equity (TTM) -32.13% |
Profit Margin N/A | Debt to Equity 0.05 | Quarterly Earnings Growth YoY -19.15% |
Edgewise Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Edgewise Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. Its lead product candidate, EDG-5506, an orally administered small molecule that is in Phase II clinical trials, designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy. The company develops EDG-7500, a small molecule for the treatment of hypertrophic cardiomyopathy and other severe cardiac disorders that is in Phase I clinical trials. In addition, it develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. The company was incorporated in 2017 and is headquartered in Boulder, Colorado.
Edgewise Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $38.48 | $44.24 | +15.12% |
Jul 2026 | $40.97 | $38.43 | -5.41% |
Jun 2026 | $40.53 | $40.63 | +18.96% |
May 2026 | $30.80 | $34.16 | +10.32% |
Apr 2026 | $32.63 | $30.96 | -1.68% |
Mar 2026 | $30.07 | $31.49 | +3.47% |
Feb 2026 | $28.13 | $30.43 | +8.10% |
Jan 2026 | $25.08 | $28.16 | +13.51% |
Dec 2025 | $26.08 | $24.80 | -4.85% |
Nov 2025 | $18.38 | $26.07 | +42.46% |
Oct 2025 | $16.19 | $18.30 | +12.83% |
Sep 2025 | $14.55 | $16.22 | +12.95% |
EWTX Share Price FAQs
What is Edgewise Therapeutics, Inc. share price today?
What is the 52 week high and 52 week low of Edgewise Therapeutics, Inc. stock?
What is EWTX's market capitalisation today?
What is EWTX's net income for the last quarter?
What is the 5 year returns of EWTX?
What is the high & low stock price of EWTX today?
Can I buy EWTX shares in India?